Poster Session 60RCC: MEDICAL TREAT MENTSunday, 20 March, 15.45-17.15, Hall H725 SEQUENTIAL USE OF MTOR -INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): SAFETY AND EFFICACY FOLLOWING FAILURE OF RECEPTOR TYROSINE KINASE INHIBITOR (TKI) TREATMENT
暂无分享,去创建一个
M. Johannsen | V. Grünwald | J. Busch | K. Miller | C. Kempkensteffen | S. Hinz | A. Magheli | S. Weikert | L. Weinkauf